63 THE FEASIBILITY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) THERAPY IN TYPE 1 DIABETIC CHILDREN AND ADOLESCENTS IN A PRIVATE PEDIATRIC ENDOCRINE PRACTICE. (1st January 2004)